Cathal Friel
Fondatore presso HVIVO PLC
Patrimonio netto: 13 M $ in data 30/04/2024
Relazioni attive
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Rory Nealon | M | 56 |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | 9 anni |
Brendan Buckley | M | 73 | 6 anni | |
Stephen Pinkerton | M | 61 | 7 anni | |
Martin Gouldstone | M | 57 | 2 anni | |
Ian O'Connell | M | 37 | 13 anni | |
Yamin Khan | M | 55 | 3 anni | |
Ryan Muldoon | M | - |
PrEP Biopharm Ltd.
PrEP Biopharm Ltd. Pharmaceuticals: MajorHealth Technology PrEP Biopharm Ltd. develops and manufactures biopharmaceutical products. The British company was founded in 2015 by Ryan Muldoon and Bruce A. Malcolm. Ryan Muldoon has been the CEO since 2015. | 9 anni |
Elaine Sullivan | M | 63 | 4 anni | |
Bruno Speder | M | - | 4 anni | |
Eddie Gibson | M | 50 | 3 anni | |
Gerry Sheehan | M | - |
T5 Oil & Gas Ltd.
T5 Oil & Gas Ltd. Oil & Gas ProductionEnergy Minerals T5 Oil & Gas Ltd. explores oil and gas resources. The firm develops portfolio of conventional oil and gas resources. The company was incorporated by Patrick Joseph Plunkett, Gerry Sheehan, Matthew O'Donoghue, Andrew Guy Windham and Stephen James McTiernan on August 07, 2013 and is headquartered in London, the United Kingdom. | 10 anni |
Andrew Catchpole | M | - | 4 anni | |
Jeremy Skillington | M | 53 | 3 anni | |
Luke O'Neill | M | 60 | - | |
Reid Tripp | M | - | 10 anni | |
Jim Cornelius | M | - |
PrEP Biopharm Ltd.
PrEP Biopharm Ltd. Pharmaceuticals: MajorHealth Technology PrEP Biopharm Ltd. develops and manufactures biopharmaceutical products. The British company was founded in 2015 by Ryan Muldoon and Bruce A. Malcolm. Ryan Muldoon has been the CEO since 2015. | - |
Mohammed Khan | M | 55 | - | |
Adam French | M | - | 2 anni | |
Mariya Kalinova | F | - | 10 anni | |
Carol Dalton | F | - | 3 anni | |
Patrick Joseph Plunkett | M | 74 |
T5 Oil & Gas Ltd.
T5 Oil & Gas Ltd. Oil & Gas ProductionEnergy Minerals T5 Oil & Gas Ltd. explores oil and gas resources. The firm develops portfolio of conventional oil and gas resources. The company was incorporated by Patrick Joseph Plunkett, Gerry Sheehan, Matthew O'Donoghue, Andrew Guy Windham and Stephen James McTiernan on August 07, 2013 and is headquartered in London, the United Kingdom. | 10 anni |
John McEvoy | M | 37 | - | |
Christian Klinkenberg | M | - |
Raglan Capital Ltd.
Raglan Capital Ltd. Investment ManagersFinance Raglan Capital Ltd. is an Irish company that specializes in creating in-house companies for rapid listing on the London Stock Exchange. Raglan Capital aims to create one new company per year and achieve an IPO within three years. The private company has offices in Ireland, the UK, and the US. The company's portfolio includes companies such as Poolbeg Pharma, HVIVO, Amryt Pharma, Fastnet Oil & Gas, and European Green Metals. The company was founded in 2007 by Cathal Martin Friel, who has been the CEO since incorporation. | - |
Michael Judson | M | - |
T5 Oil & Gas Ltd.
T5 Oil & Gas Ltd. Oil & Gas ProductionEnergy Minerals T5 Oil & Gas Ltd. explores oil and gas resources. The firm develops portfolio of conventional oil and gas resources. The company was incorporated by Patrick Joseph Plunkett, Gerry Sheehan, Matthew O'Donoghue, Andrew Guy Windham and Stephen James McTiernan on August 07, 2013 and is headquartered in London, the United Kingdom. | 7 anni |
Matthew O'Donoghue | M | - |
T5 Oil & Gas Ltd.
T5 Oil & Gas Ltd. Oil & Gas ProductionEnergy Minerals T5 Oil & Gas Ltd. explores oil and gas resources. The firm develops portfolio of conventional oil and gas resources. The company was incorporated by Patrick Joseph Plunkett, Gerry Sheehan, Matthew O'Donoghue, Andrew Guy Windham and Stephen James McTiernan on August 07, 2013 and is headquartered in London, the United Kingdom. | 10 anni |
Martin Ewart Johnson | M | - | - | |
David Allmond | M | 54 | 1 anni | |
Ross Crockett | M | - | 3 anni | |
Clive Page | M | 66 |
PrEP Biopharm Ltd.
PrEP Biopharm Ltd. Pharmaceuticals: MajorHealth Technology PrEP Biopharm Ltd. develops and manufactures biopharmaceutical products. The British company was founded in 2015 by Ryan Muldoon and Bruce A. Malcolm. Ryan Muldoon has been the CEO since 2015. | - |
Laura Maher | F | - | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
Nome | Sesso | Età | Società collegate | Collaborazione |
---|---|---|---|---|
Leo Toole | M | 51 | 3 anni | |
Joe Wiley | M | 53 |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | 8 anni |
Aneshkumar Patel | M | 43 | 5 anni | |
Ray Stafford | M | 77 |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | 7 anni |
Fleur Wood | M | - | 2 anni | |
Anthony Culverwell | M | 68 |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | 3 anni |
Trevor Phillips | M | 63 | - | |
Patrick Ashe | M | 59 | - | |
Michael Gerald Meade | M | 64 | 1 anni | |
Mark Robert Warne | M | 49 | - | |
David Kelly | M | 63 | 1 anni | |
Christian Bernard Milla | M | 61 | 3 anni | |
Markus Ziener | M | 58 |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | 3 anni |
John Murphy | M | - |
University of Ulster
| 4 anni |
Andrew Guy Windham | M | 74 |
T5 Oil & Gas Ltd.
T5 Oil & Gas Ltd. Oil & Gas ProductionEnergy Minerals T5 Oil & Gas Ltd. explores oil and gas resources. The firm develops portfolio of conventional oil and gas resources. The company was incorporated by Patrick Joseph Plunkett, Gerry Sheehan, Matthew O'Donoghue, Andrew Guy Windham and Stephen James McTiernan on August 07, 2013 and is headquartered in London, the United Kingdom. | 4 anni |
Maurice N. Treacy | M | 62 | 1 anni | |
Gary Keating | M | 51 |
University of Ulster
| 4 anni |
Salim Hamir | M | - | - | |
Kieran Hegarty | M | 57 |
University of Ulster
| 1 anni |
Helen Phillips | M | - |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | - |
Antony Barker | M | - |
University of Ulster
| 3 anni |
Mark Sumeray | M | 58 |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | 6 anni |
Martin Armstrong | M | 58 |
University of Ulster
| 4 anni |
Michael Ryan | M | 67 | 8 anni | |
Tsz Keung Yeung | M | 59 |
University of Ulster
| 4 anni |
Chee Hong Leong | M | 58 |
University of Ulster
| 4 anni |
Soo Beng Khor | M | 61 |
University of Ulster
| 4 anni |
Yiu Wah Chow | M | 65 |
University of Ulster
| 4 anni |
John Macrae | M | - |
University of Ulster
| 2 anni |
Alan Gibson | M | - |
University of Ulster
| 2 anni |
Malachy McGuinness | M | - |
University of Ulster
| 4 anni |
Harry Thomas Stratford | M | 54 |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | 3 anni |
Thomas Gerard Bryce | M | 55 |
University of Ulster
| 4 anni |
Anthony Francis Richardson | M | 59 | - | |
David English | M | - | 1 anni |
Statistiche
Paese | Relazioni | % del totale |
---|---|---|
Regno Unito | 64 | 98.46% |
Irlanda | 1 | 1.54% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Cathal Friel
- Contatti personali